Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Correction to Discovery and Optimization of Indolyl-Containing 4-Hydroxy-2-pyridone Type II DNA Topoisomerase Inhibitors Active against Multidrug Resistant Gram-Negative Bacteria.

Gerasyuto AI, Arnold MA, Wang J, Chen G, Zhang X, Smith S, Woll MG, Baird J, Zhang N, Almstead NG, Narasimhan J, Peddi S, Dumble M, Sheedy J, Weetall M, Branstrom AA, Prasad JVN, Karp GM.

J Med Chem. 2018 Oct 25;61(20):9394. doi: 10.1021/acs.jmedchem.8b01538. Epub 2018 Oct 16. No abstract available.

2.

Discovery and Optimization of Indolyl-Containing 4-Hydroxy-2-Pyridone Type II DNA Topoisomerase Inhibitors Active against Multidrug Resistant Gram-negative Bacteria.

Gerasyuto AI, Arnold MA, Wang J, Chen G, Zhang X, Smith S, Woll MG, Baird J, Zhang N, Almstead NG, Narasimhan J, Peddi S, Dumble M, Sheedy J, Weetall M, Branstrom AA, Prasad JVN, Karp GM.

J Med Chem. 2018 May 24;61(10):4456-4475. doi: 10.1021/acs.jmedchem.8b00114. Epub 2018 May 14. Erratum in: J Med Chem. 2018 Oct 25;61(20):9394.

3.

4-Hydroxy-2-pyridones: Discovery and evaluation of a novel class of antibacterial agents targeting DNA synthesis.

Arnold MA, Gerasyuto AI, Wang J, Du W, Gorske YJK, Arasu T, Baird J, Almstead NG, Narasimhan J, Peddi S, Ginzburg O, Lue SW, Hedrick J, Sheedy J, Lagaud G, Branstrom AA, Weetall M, Prasad JVNV, Karp GM.

Bioorg Med Chem Lett. 2017 Nov 15;27(22):5014-5021. doi: 10.1016/j.bmcl.2017.10.006. Epub 2017 Oct 5.

PMID:
29032026
4.

Structure of Francisella tularensis peptidyl-tRNA hydrolase.

Clarke TE, Romanov V, Lam R, Gothe SA, Peddi SR, Razumova EB, Lipman RS, Branstrom AA, Chirgadze NY.

Acta Crystallogr Sect F Struct Biol Cryst Commun. 2011 Apr 1;67(Pt 4):446-9. doi: 10.1107/S174430911100515X. Epub 2011 Mar 26.

5.

PTC124 targets genetic disorders caused by nonsense mutations.

Welch EM, Barton ER, Zhuo J, Tomizawa Y, Friesen WJ, Trifillis P, Paushkin S, Patel M, Trotta CR, Hwang S, Wilde RG, Karp G, Takasugi J, Chen G, Jones S, Ren H, Moon YC, Corson D, Turpoff AA, Campbell JA, Conn MM, Khan A, Almstead NG, Hedrick J, Mollin A, Risher N, Weetall M, Yeh S, Branstrom AA, Colacino JM, Babiak J, Ju WD, Hirawat S, Northcutt VJ, Miller LL, Spatrick P, He F, Kawana M, Feng H, Jacobson A, Peltz SW, Sweeney HL.

Nature. 2007 May 3;447(7140):87-91. Epub 2007 Apr 22.

PMID:
17450125
6.

Synthesis and mode of action of hydrophobic derivatives of the glycopeptide antibiotic eremomycin and des-(N-methyl-D-leucyl)eremomycin against glycopeptide-sensitive and -resistant bacteria.

Printsevskaya SS, Pavlov AY, Olsufyeva EN, Mirchink EP, Isakova EB, Reznikova MI, Goldman RC, Branstrom AA, Baizman ER, Longley CB, Sztaricskai F, Batta G, Preobrazhenskaya MN.

J Med Chem. 2002 Mar 14;45(6):1340-7.

PMID:
11882003
7.

Genetic basis for activity differences between vancomycin and glycolipid derivatives of vancomycin.

Eggert US, Ruiz N, Falcone BV, Branstrom AA, Goldman RC, Silhavy TJ, Kahne D.

Science. 2001 Oct 12;294(5541):361-4. Epub 2001 Aug 23.

8.

Synthesis of hydrophobic N'-mono and N',N"-double alkylated eremomycins inhibiting the transglycosylation stage of bacterial cell wall biosynthesis.

Pavlov AY, Miroshnikova OV, Printsevskaya SS, Olsufyeva EN, Preobrazhenskaya MN, Goldman RC, Branstrom AA, Baizman ER, Longley CB.

J Antibiot (Tokyo). 2001 May;54(5):455-9.

9.

Synthesis and biological evaluation of analogues of bacterial lipid I.

Silva DJ, Bowe CL, Branstrom AA, Baizman ER, Sofia MJ.

Bioorg Med Chem Lett. 2000 Dec 18;10(24):2811-3.

PMID:
11133098
10.

Antibacterial activity of synthetic analogues based on the disaccharide structure of moenomycin, an inhibitor of bacterial transglycosylase.

Baizman ER, Branstrom AA, Longley CB, Allanson N, Sofia MJ, Gange D, Goldman RC.

Microbiology. 2000 Dec;146 Pt 12:3129-40.

PMID:
11101671
11.

Differential antibacterial activity of moenomycin analogues on gram-positive bacteria.

Goldman RC, Baizman ER, Branstrom AA, Longley CB.

Bioorg Med Chem Lett. 2000 Oct 16;10(20):2251-4.

PMID:
11055331
12.

In situ assay for identifying inhibitors of bacterial transglycosylase.

Branstrom AA, Midha S, Goldman RC.

FEMS Microbiol Lett. 2000 Oct 15;191(2):187-90.

13.

Assay for identification of inhibitors for bacterial MraY translocase or MurG transferase.

Branstrom AA, Midha S, Longley CB, Han K, Baizman ER, Axelrod HR.

Anal Biochem. 2000 May 1;280(2):315-9.

PMID:
10790316
14.
15.

Attenuated bacteria as a DNA delivery vehicle for DNA-mediated immunization.

Sizemore DR, Branstrom AA, Sadoff JC.

Vaccine. 1997 Jun;15(8):804-7.

PMID:
9234519
16.

Interaction of Salmonella typhi strains with cultured human monocyte-derived macrophages.

Sizemore DR, Elsinghorst EA, Eck LC, Branstrom AA, Hoover DL, Warren RL, Rubin FA.

Infect Immun. 1997 Jan;65(1):309-12.

17.

Attenuated Shigella as a DNA delivery vehicle for DNA-mediated immunization.

Sizemore DR, Branstrom AA, Sadoff JC.

Science. 1995 Oct 13;270(5234):299-302.

PMID:
7569980
18.
19.

Supplemental Content

Loading ...
Support Center